---
title: Group Meetings
date: '2022-08-23T03:00:00.000+00:00'
heading: Group Meetings
publish_date: '2022-08-23T03:00:00.000+00:00'
menu:
  navigation:
    identifier: _groupmeetings
    weight: 4

---

The Drown Lab meets weekly on Mondays at 5pm in 1152 BRWN

In the period before students join research group, Dr. Drown will present literature reviews
in the areas of chemical biology and proteomics.

## Schedule

### September 12, 2022 - Small-molecule Probe Development - [Stuart Schreiber](https://www.broadinstitute.org/schreiber-lab) in focus:
The Schreiber group has led the way in developing approaches for small-molecule probe discovery. Stuart Schreiber has made significant discoveries in the areas of drug target elucidation, printed microarrays, and diversity oriented synthesis.
 - Schreiber, S. L. [Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery](https://doi.org/10.1126/science.287.5460.196). Science 2000, 287 (5460), 1964–1969. 4.
 - Nielsen, T. E.; Schreiber, S. L. [Towards the Optimal Screening Collection: A Synthesis Strategy](https://doi.org/10.1002/anie.200703073). Angewandte Chemie Int Ed 2007, 47 (1), 48–56. .
 - Kato, N.; Schreiber, S. L. [Diversity-Oriented Synthesis Yields Novel Multistage Antimalarial Inhibitors](https://doi.org/10.1038/nature19804). Nature 2016, 538 (7625), 344–349.
 - Liu, J.; Schreiber, S. L. [Calcineurin Is a Common Target of Cyclophilin-Cyclosporin A and FKBP-FK506 Complexes](https://doi.org/10.1016/0092-8674(91)90124-h). Cell 1991, 66 (4), 807–815.
 - Brown, E. J.; Schreiber, S. L. [A Mammalian Protein Targeted by G1-Arresting Rapamycin–Receptor Complex](https://doi.org/10.1038/369756a0). Nature 1994, 369 (6483), 756–758.
 - Rees, M. G.; Schreiber, S. L. [Correlating Chemical Sensitivity and Basal Gene Expression Reveals Mechanism of Action](https://doi.org/10.1038/nchembio.1986). Nat Chem Biol 2016, 12 (2), 109–116.

### September 5, 2022 - Labor Day (no meeting)

### August 29, 2022 - Bio-orthogonal Reactions - [Carolyn Bertozzi](https://chemistry.stanford.edu/people/carolyn-bertozzi) in focus:
The Bertozzi group has innovated at the forefront of bio-orthogonal reaction design and application. Several key publications will be discussed.
 - Saxon, E.; Bertozzi, C. R. [Cell Surface Engineering by a Modified Staudinger Reaction](https://doi.org/10.1126/science.287.5460.2007). *Science* **2000**, 287 (5460), 2007–2010.
 - Agard, N. J.; Prescher, J. A.; Bertozzi, C. R. [A Strain-Promoted [3 + 2] Azide−Alkyne Cycloaddition for Covalent Modification of Biomolecules in Living Systems](https://doi.org/10.1021/ja044996f). *J. Am. Chem. Soc.* **2004**, 126 (46), 15046–15047.
 - Hudak, J. E.; Canham, S. M.; Bertozzi, C. R. [Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion](https://doi.org/10.1038/nchembio.1388). *Nat. Chem. Biol.* **2014**, 10 (1), 69–75.
 - Gray, M. A.; Stanczak, M. A.; Mantuano, N. R.; Xiao, H.; Pijnenborg, J. F. A.; Malaker, S. A.; Miller, C. L.; Weidenbacher, P. A.; Tanzo, J. T.; Ahn, G.; Woods, E. C.; Läubli, H.; Bertozzi, C. R. [Targeted Glycan Degradation Potentiates the Anticancer Immune Response in Vivo](https://doi.org/10.1038/s41589-020-0622-x). *Nat. Chem. Biol.* **2020**, 16 (12), 1376–1384.
  
  
